Palvella Therapeutics (PVLA) Return on Capital Employed: 2015-2024
Historic Return on Capital Employed for Palvella Therapeutics (PVLA) over the last 10 years, with Sep 2024 value amounting to 0.20%.
- Palvella Therapeutics' Return on Capital Employed rose 102.00% to 0.20% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.20%, marking a year-over-year increase of 102.00%. This contributed to the annual value of -0.24% for FY2023, which is 25.00% up from last year.
- According to the latest figures from Q3 2024, Palvella Therapeutics' Return on Capital Employed is 0.20%, which was up 233.73% from -0.15% recorded in Q2 2024.
- Over the past 5 years, Palvella Therapeutics' Return on Capital Employed peaked at 0.20% during Q3 2024, and registered a low of -1.12% during Q1 2023.
- Over the past 3 years, Palvella Therapeutics' median Return on Capital Employed value was -0.55% (recorded in 2022), while the average stood at -0.47%.
- As far as peak fluctuations go, Palvella Therapeutics' Return on Capital Employed crashed by 61bps in 2023, and later skyrocketed by 129bps in 2024.
- Over the past 5 years, Palvella Therapeutics' Return on Capital Employed (Quarterly) stood at -0.38% in 2020, then fell by 9bps to -0.48% in 2021, then dropped by 24bps to -0.72% in 2022, then skyrocketed by 33bps to -0.38% in 2023, then surged by 102bps to 0.20% in 2024.
- Its Return on Capital Employed stands at 0.20% for Q3 2024, versus -0.15% for Q2 2024 and 0.17% for Q1 2024.